Delivery Order SPE2DR25D2014-SPE2DR26FA2J5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Nemluvio 30 mg pens, with a ceiling value of $1,867.72. This firm fixed-price delivery order is scheduled for ultimate completion by November 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a $2,033.08 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Nemluvio 30 mg pens. This is a firm fixed-price, competitively awarded contract with a completion date of December 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award is issued under a larger Indefinite Delivery Contract vehicle. This delivery order falls under...
- The Defense Logistics Agency awarded a $2,033.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for supply of Nemluvio 30 mg pens, with completion targeted for February 4, 2026. This is a non-set-aside, competitively awarded contract with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,099.24 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Nemluvio 30 mg pens. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured without set-aside designation, demonstrating AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This firm fixed-price delivery order, issued on December 1, 2025, with completion expected by December 22, 2025, represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. The award was made on December 9, 2025, with an ultimate completion date of December 31, 2025, under a firm fixed-price contract type with no set-aside designation. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued against AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.08 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Nemluvio 30 mg pens, with a completion deadline of December 31, 2025. This firm fixed-price, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $7,471 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for supply of Nemluvio 30 mg pens. The contract is a firm fixed-price, competitive award with no set-aside designation and is scheduled for completion by November 28, 2025. AmerisourceBergen will perform this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $6,099.24 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens on December 15, 2025, with an ultimate completion date of January 7, 2026. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 2, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2J5Delivery Order
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This non-competitive, firm fixed-price delivery order is scheduled for completion by February 4, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime vendor agreement that extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves critical federal medical procurement needs across military and veteran healthcare systems. The company maintains significant standing within the federal supply chain through its extensive portfolio of pharmaceutical products and medical supplies delivered under competitive, non-set-aside contracts with the Defense Logistics Agency. This particular delivery order for specialty diabetes medication supports the Defense Health Agency and broader military treatment facility requirements, leveraging the company's established capability to efficiently fulfill government pharmaceutical procurement across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 1/12/26 |